Investigating brain mechanisms and new treatment modalities for persistent postural-perceptual dizziness (PPPD)

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0005068

Enrollment

Registered

2020-05-28

Start date

2019-02-15

Completion date

Unknown

Last updated

2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : (1) Active tDCS group: 2mA tdcs 20 minutes daily, 5 times per week, 3 weeks, total of 15 times on the prefrontal cortex. (2) Sham tDCS group: sham tdcs 20 minutes daily, 5 times per w

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. PPPD group - Men and women between the ages of 18 and 69 - Meeting the diagnostic criteria for persistent postural-perceptual dizziness (PPPD) of the Barany Society for diagnosis of dizziness 2. Control group - Men and women between the ages of 18 and 69

Exclusion criteria

Exclusion criteria: - Have major medical, neurological (excluding PPPD), or psychiatric disorders - If pregnant, breast-feeding, or have a pregnancy plan - Not suitable for MRI and SPECT imaging (in-body metal and medical devices, claustrophobia, etc.) - If there is a problem attaching tDCS electrodes due to deformity, inflammatory response, or other dermatological problems of the scalp (PPPD group only) - Loss of consciousness for more than an hour due to other causes other than general anesthesia - Has been hospitalized with a head injury

Design outcomes

Primary

Measure	Time frame
Severity of dizziness symptoms	—

Secondary

Measure	Time frame
Adverse events;Single-photon emission computed tomography Imaging	—

Countries

Korea, Republic of

Contacts

Public ContactJooyeon Im

The Catholic University of Korea, Incheon St. Mary's Hospital

Outcome results